Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinfukang Koufuye in Postoperative NSCLC
NCT03269162Phase 3Unknown
- Sponsor
- Lihegen
- Start
- Sep 2016
- Primary completion
- Sep 2019
01
Overview
A Phase 3 trial of jinfukang in non-small cell lung cancer (NSCLC), sponsored by Lihegen. Status: unknown.
02
Drugs
jinfukang
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03269162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03269162.